Prophylactic surgery in Lynch syndrome

Techniques in Coloproctology

Volumn 15, Issue 2, 2011, Pages 129-134

  Celentano, V ^a   Luglio, G ^a   Antonelli, G ^a   Tarquini, R ^a   Bucci, L ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Hereditary nonpolyposis colorectal cancer; Lynch syndrome; Prophylactic surgery

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADENOMATOUS POLYP; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CAUSAL ATTRIBUTION; CLINICAL EFFECTIVENESS; COLON POLYP; COLON RESECTION; COLONOSCOPY; ENDOMETRIUM CANCER; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; ILEORECTAL ANASTOMOSIS; MISMATCH REPAIR; ONSET AGE; OVARIECTOMY; OVARY CANCER; OVERALL SURVIVAL; PERFORATION; POLYPECTOMY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PROCTOCOLECTOMY; QUALITY OF LIFE; REVIEW; STRATEGIC PLANNING; TREATMENT PLANNING;

COLECTOMY; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OVARIAN NEOPLASMS;

EID: 80051666902     PISSN: 11236337     EISSN: 1128045X     Source Type: Journal    
DOI: 10.1007/s10151-010-0666-0     Document Type: Review

References (64)

1. Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348:919-932 (Pubitemid 36298000)
2. Aaltonen LA, Salovaara R, Kristo P et al (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338: 1481-1487 (Pubitemid 28226275)
3. Percesepe A, Borghi F, Menigatti M et al (2001) Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. J Clin Oncol 19:3944-3950 (Pubitemid 32912021)
4. Rouprêt M, Yates DR, Comperat E, Cussenot O (2008) Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Eur Urol 54:1226-1236
5. Soravia C, van der Klift H, Bründler MA et al (2003) Prostate cancer is part of the hereditary non-polyposis colorectal cancer (HNPCC) tumor spectrum. Am J Med Genet A 121A:159-162 (Pubitemid 37075523)
6. Risinger JI, Barrett JC, Watson P, Lynch HT, Boyd J (1996) Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 77:1836-1843 (Pubitemid 26125184)
7. Medina Arana V, Barrios del Pino Y, García-Castro C, González-Aguilera JJ, Fernández-Peralta A, González-Hermoso F (2002) Highly aggressive leiomyosarcoma associated with Lynch II syndrome. Ann Oncol 13:807-808
8. Huang RL, Chao CF, Ding DC et al (2004) Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MHS2 gene and heterogeneity of replication error phenotypes. Cancer Genet Cytogenet 153:108-114
9. Salovaara R, Loukola A, Kristo P et al (2000) Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 18:2193-2200 (Pubitemid 30350210)
10. Molatore S, Ranzani GN (2004) Genetics of colorectal polyps. Tech Coloproctol 2:S240-S242 (Pubitemid 40202477)
11. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Ruschoff J (1997) Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 57:4749-4756 (Pubitemid 27468981)
12. Bronner CE, Baker SM, Morrison PT et al (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colorectal cancer. Nature 368: 258-261
13. Leach FS, Nicolaides NC, Papadopoulos N et al (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215-1225 (Pubitemid 24006117)
14. Nicolaides NC, Papadopoulos N, Liu B et al (1994) Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371:75-80 (Pubitemid 24277467)
15. Umar A, Boyer JC, Thomas DC et al (1994) Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J Biol Chem 269: 14367-14370 (Pubitemid 24193983)
16. Menigatti M, Di Gregorio C, Borghi F et al (2001) Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer. Genes Chromosomes Cancer 31:357-361 (Pubitemid 32622712)
17. Cunningham JM, Christensen ER, Tester DJ et al (1998) Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58:3455-3460 (Pubitemid 28371090)
18. Kastrinos F, Stoffel EM, Balmana J, Steyerberg EW, Mercado R, Syngal S (2008) Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1, 914 individuals undergoing clinical genetic testing in the United States. Cancer Epidemiol Biomarkers Prev 17:2044-2051
19. Kruse R, Rütten A, Lamberti C et al (1998) Muir-Torre pheno-type has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet 63:63-70 (Pubitemid 30428319)
20. Watson P, Vasen HF, Mecklin JP et al (2008) The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 123:444-449 (Pubitemid 351842032)
21. Plaschke J, Engel C, Krüger S et al (2004) Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 22: 4486-4494 (Pubitemid 41185114)
22. Senter L, Clendenning M, Sotamaa K et al (2008) The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 135:419-428
23. Vasen HFA, Mecklin JP, Khan PM, Lynch HT (1991) The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34:424-425
24. Vasen HFA, Watson P, Mecklin JP, Lynch HT (1999) ICG-HNPCC. New clinical criteria for hereditary nonpolyposis colo-rectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116:1453-1456 (Pubitemid 29258894)
25. Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268 (Pubitemid 38256271)
26. Wahlberg SS, Schmeits J, Thomas G et al (2002) Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res 62:3485-3492 (Pubitemid 34651396)
27. Aktan-Collan K, Mecklin JP, Järvinen H et al (2000) Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. Int J Cancer 89:44-50 (Pubitemid 30078749)
28. Lindor NM, Rabe K, Petersen GM et al (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency:familial colorectal cancer type x JAMA 293:1979-1985 (Pubitemid 40570891)
29. Vasen HFA, Wijnen JT, Menko FH et al (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110:1020-1027 (Pubitemid 26113739)
30. Love RR (1986) Adenomas are the precursor lesions for malignant growth in nonpolyposis hereditary carcinoma of the colon and rectum. Surg Gynecol Obstet 162:8-12 (Pubitemid 16154756)
31. Mecklin JP, Sipponen P, Jarvinen HJ (1986) Histopathology of colorectal carcinomas and adenomas in cancer family syndrome. Dis Colon Rectum 29:849-853 (Pubitemid 17208885)
32. Jarvinen HJ, Mecklin JP, Sistonen P (1995) Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 108:1405-1411
33. Jarvinen HJ, Aarnio M, Mustonen H et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829-834 (Pubitemid 30243745)
34. de Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G et al (2002) Surveillance for hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 45:1588-1594
35. Lindor NM, Petersen GM, Hadley DW et al (2006) Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 296:1507-1517 (Pubitemid 44465515)
36. Dove-Edwin I, Sasieni P, Adams J, Thomas HJ (2005) Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer. BMJ 331:1047
37. Mecklin JP, Aarnio M, Läärä E et al (2007) Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. Gastroenterology 133:1093-1098 (Pubitemid 47494464)
38. Tominaga K, Nakanishi Y, Nimura S, Yokimura K, Sakai Y, Shimoda T (2005) Predictive histopathologic factors for lymph node metastasis in patients with nonpedunculated submucosal invasive colorectal carcinoma. Dis Colon Rectum 48:92-100 (Pubitemid 40895660)
39. Ueno H, Mochizuki H, Hashiguchi Y et al (2004) Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 127:385-394 (Pubitemid 39091886)
40. Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD (1985) Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology 89:328-336 (Pubitemid 15028589)
41. Winawer S, Fletcher R, Rex D, Gastrointestinal Consortium Panel et al (2003) Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 124:544-560 (Pubitemid 36169269)
42. van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E (2006) Polyp miss rate determined by tandem colon-oscopy: a systematic review. Am J Gastroenterol 101:343-350 (Pubitemid 43381678)
43. Waye JD, Kahn O, Auerbach ME (1996) Complications of colonoscopy and flexible sigmoidoscopy. Gastrointest Endosc Clin N Am 6:343-377 (Pubitemid 26116046)
44. Nicholson FB, Barro JL, Atkin W et al (2005) Review article: population screening for colorectal cancer. Aliment Pharmacol Ther 22:1069-1077 (Pubitemid 41779514)
45. Rabeneck L, Paszat LF, Hilsden RJ et al (2008) Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology 135:1899-1906
46. Taku K, Sano Y, Fu KI et al (2007) Iatrogenic perforation associated with therapeutic colonoscopy: a multicenter study in Japan. J Gastroenterol Hepatol 22:1409-1414 (Pubitemid 47274585)
47. Repici A, Tricerri R (2004) Endoscopic polypectomy: techniques, complications and follow-up. Tech Coloproctol 8:S283-S290 (Pubitemid 40202487)
48. Levin TR, Zhao W, Conell C et al (2006) Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med 145:880-886 (Pubitemid 351639963)
49. Hadley DW, Jenkins JF, Dimond E, de Carvalho M, Kirsch I, Palmer CG (2004) Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 22:39-44 (Pubitemid 41095112)
50. Bleiker EM, Menko FH, Taal BG et al (2005) Screening behavior of individuals at high risk for colorectal cancer. Gastroenterology 128:280-287 (Pubitemid 40431081)
51. Syngal S, Weeks JC, Schrag D, Garber JE, Kuntz KM (1998) Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med 129:787-796 (Pubitemid 28522813)
52. de Vos tot Nederveen Cappel WH, Buskens E, van Duijvendijk P et al (2003) Decision analysis in the surgical treatment of colo-rectal cancer due to a mismatch repair gene defect. Gut 52:1752-1755 (Pubitemid 37510398)
53. Natarajan N, Watson P, Silva-Lopez E, Lynch HT (2010) Comparison of extended colectomy and limited resection in patients with Lynch syndrome. Dis Colon Rectum 53:77-82
54. Rodriguez-Bigas MA, Vasen HF, Pekka-Mecklin J et al (1997) International Collaborative Group on HNPCC. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. Ann Surg 225:202-207 (Pubitemid 27083780)
55. Meyer LA, Broaddus RR, Lu KH (2009) Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Control 16:14-22
56. Aarnio M, Sankila R, Pukkala E et al (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81:214-218 (Pubitemid 29144749)
57. Aarnio M, Mecklin JP, Aaltonen LA, Nyström-Lahti M, Järvinen HJ (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64:430-433 (Pubitemid 26048907)
58. Offit K, Kauff ND (2006) Reducing the risk of gynecologic cancer in the Lynch syndrome. N Engl J Med 354:293-295 (Pubitemid 43113037)
59. Dunlop MG, Farrington SM, Carothers AD et al (1997) Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6:105-110 (Pubitemid 27033972)
60. Schmeler KM, Lynch HT, Chen LM et al (2006) Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354:261-269 (Pubitemid 43113031)
61. Vasen HF, Stormorken A, Menko FH et al (2001) MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 19:4074-4080 (Pubitemid 32976695)
62. Watson P, Bützow R, Lynch HT et al (2001) The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 82:223-228 (Pubitemid 32730595)
63. Lynch HT, Casey MJ (2007) Prophylactic surgery prevents endometrial and ovarian cancer in Lynch syndrome. Nat Clin Pract Oncol 4:672-673 (Pubitemid 350186997)
64. Renkonen-Sinisalo L, Bützow R, Leminen A, Lehtovita P, Mecklin JP, Järvinen HJ (2007) Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer 120:821-824 (Pubitemid 46175402)